Trial Profile
Effect of Clopidogrel (Plavix) on Postoperative Bleeding in Patients Undergoing Coronary Artery Bypass Surgery. A Prospective Randomized Controlled Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2009
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Adverse reactions
- 21 Aug 2008 New trial record.